FDA NDC Directory · JSON-LD · Markdown
NDC 51754-0203 · HUMAN PRESCRIPTION DRUG · INJECTION
| Labeler / Manufacturer | EXELA PHARMA SCIENCES, LLC |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA018925 |
| Dosage form / route | INJECTION · INTRAVENOUS |
| Active ingredients | VERAPAMIL HYDROCHLORIDE (2.5 mg/mL) |
| Marketing started | 20160422 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).